King Pharma (KG) Beat Q3 Views by 2c
More News related to KG
- Notable 52-Week NYSE New Highs and Lows 11/19: CAH, DCI, RX, KG, MRK, TSL Highs; SNV, WNR Low
- StockPreacher.com Issues Trading Outlook for Arena Pharmaceuticals Inc.
- King Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
- Trading Outlook for ZymoGenetics Inc. Issued by StockPreacher.com
- Wedbush Upgrades ZymoGenetics (ZGEN) to Outperform; Believe ZGEN on Track to Meet 2010 Sales Estimates
More News related to Earnings
- After-Hours Movers 11/23: CNO, RMBS, NUAN, ADI Higher; HAYN, DY, DBLE, CISG, IPAR, KWR Lower
- Trading Radar for 11/24: Heinz (HNZ), Dollar Tree (DLTR), Eaton Vance (EV), Hormel Foods (HRL), J. Crew (JCG) Report
- Afternoon ETF Check: GDX, KBE Higher; UUP Lower
- Unusual 11 Mid-Day Movers 11/23: ABIO, SEED, FNET, CDTI Higher; NYNY, GGR, TTIL, PEET Lower
- Best of the Web 11/23: Suicides On the Rise, U.S. Debt Service Could Top $700B, Really? An Insider Trading Beauty Queen
King Pharmaceuticals (NYSE: KG) reports Q3 EPS of $0.29, 2 cents better than the analyst estimate of $0.27. Revenue for the quarter was $463 million, which compares to the estimate of $444.98 million.
Related Categories
EarningsStocks Mentioned
+0.26Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
